EODData

MEMBERSHIP REGISTER LOG IN

FRA, I9DN: Arbutus Biopharma Corp

21 Aug 2026
LAST:

4.010

CHANGE:
 0.19		OPEN:
4.010		HIGH:
4.010		ASK:
0.000		VOLUME:
0
CHG(%):
4.52		PREV:
4.200		LOW:
4.010		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
21 Aug 264.0104.0104.0104.0100
20 Aug 264.2104.2204.2004.2000
19 Aug 264.1004.1004.1004.1000
18 Aug 264.0104.1304.0104.1300
17 Aug 263.9903.9903.9903.9900
14 Aug 263.9203.9203.9203.9200
13 Aug 263.9103.9103.9103.9100
12 Aug 263.9903.9903.9903.9900
07 Aug 263.8803.8803.8803.8800
06 Aug 263.9303.9303.9303.9300

PROFILE

Name:Arbutus Biopharma Corp
About:Arbutus Biopharma Corporation, a clinical-stage biopharmaceutical company, develops novel therapeutics for infectious disease in the United States. Its chronic Hepatitis B virus product pipeline comprises Imdusiran, conjugated GalNAc, subcutaneously-delivered RNAi therapeutic product candidate which is in phase 1 and phase 2a clinical trials that suppresses all HBV antigens, including HBsAg expression; and AB-101, an oral PD-L1 inhibitor, which is in phase 1a/1b clinical trial that has the potential to reawaken patients' HBV-specific immune response by inhibiting PD-L1. The company has licensing agreement with Alnylam Pharmaceuticals, Inc. to develop and commercialize products with LNP delivery technology. The company was formerly known as Tekmira Pharmaceuticals Corporation and changed its name to Arbutus Biopharma Corporation in July 2015. Arbutus Biopharma Corporation was incorporated in 2005 is headquartered in Warminster, Pennsylvania.
Sector:Healthcare
Industry:Biotechnology
Address:701 Veterans Circle, Warminster, PA, United States, 18974
Website:https://www.arbutusbio.com
ISIN:CA03879J1003

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:5.85 
Forward P/E:-5.41 
PEG Ratio:-0.01 
Price to Sales:4.41 
Price to Book:3.68 
Profit Margin:0.84 
Operating Margin:0.94 
Return on Assets:0.49 
Return on Equity:0.95 
Revenue:167.71M 
EBITDA:135.9M 
Shares:191.7M 
Market Cap:768.71M 

TECHNICAL INDICATORS

MA5:4.091.9%
MA10:4.010.1%
MA20:3.902.9%
MA50:3.931.9%
MA100:3.824.9%
MA200:3.776.3%
STO9:38.24
STO14:61.11
RSI14:57.36
WPR14:-36.54
MTM14:0.33
ROC14:0.09 
ATR:0.09 
Week High:4.225.2%
Week Low:3.922.3%
Month High:4.225.2%
Month Low:3.686.3%
Year High:4.5112.5%
Year Low:2.9536.1%